ArticleThe Lancet regional health. Southeast Asia2024

Deferoxamine, deferasirox, and deferiprone triple iron chelator combination therapy for transfusion-dependent β-thalassaemia with very high iron overload: a randomised clinical trial.

Anuja Premawardhena et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.